20 related articles for article (PubMed ID: 32771615)
1. The Impact of the COVID-19 Pandemic on Adherence to Endocrine Therapy for Breast Cancer in Catalonia (Spain).
Navarro-Sabate A; Font R; Martínez-Soler F; Solà J; Tortosa A; Ribes J; Benito-Aracil L; Espinas JA; Borras JM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275867
[No Abstract] [Full Text] [Related]
2. Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial.
Ciruelos E; Villagrasa P; Pascual T; Oliveira M; Pernas S; Paré L; Escrivá-de-Romaní S; Manso L; Adamo B; Martínez E; Cortés J; Vazquez S; Perelló A; Garau I; Melé M; Martínez N; Montaño A; Bermejo B; Morales S; Echarri MJ; Vega E; González-Farré B; Martínez D; Galván P; Canes J; Nuciforo P; Gonzalez X; Prat A
Clin Cancer Res; 2020 Nov; 26(22):5820-5829. PubMed ID: 32938620
[TBL] [Abstract][Full Text] [Related]
3. Facing problems in radiotherapy for breast cancer patients in Yogyakarta, Indonesia: A cohort retrospective study.
Suryanegara FDA; Rokhman MR; Ekaputra E; de Jong LA; Setiawan D; de Bock GH; Postma MJ
Cancer Med; 2023 Apr; 12(7):8851-8859. PubMed ID: 36680328
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Adopting Hypofractionated Radiotherapy as a Standard of Care in Low-and Middle-Income Countries.
Kraus RD; Weil CR; Abdel-Wahab M
JCO Glob Oncol; 2022 Dec; 8():e2200215. PubMed ID: 36525619
[No Abstract] [Full Text] [Related]
5. Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.
Font R; Espinas JA; Barnadas A; Izquierdo A; Galceran J; Saladie F; Marcos-Gragera R; Torrent A; Manchon-Walsh P; Borras JM
Breast Cancer Res Treat; 2019 Jun; 175(3):733-740. PubMed ID: 30887164
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
Wollschläger D; Meng X; Wöckel A; Janni W; Kreienberg R; Blettner M; Schwentner L
Breast J; 2018 Mar; 24(2):120-127. PubMed ID: 28685896
[TBL] [Abstract][Full Text] [Related]
7. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
[TBL] [Abstract][Full Text] [Related]
8. A population perspective on the use of external beam radiotherapy in Catalonia, Spain.
Corral J; Solà J; Galceran J; Marcos-Gragera R; Carulla M; Izquierdo Á; Vilardell L; Llauradó L; Espinàs JA; Borras JM
Clin Transl Oncol; 2020 Dec; 22(12):2222-2229. PubMed ID: 32424700
[TBL] [Abstract][Full Text] [Related]
9. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
10. A systematic overview of radiation therapy effects in prostate cancer.
Nilsson S; Norlén BJ; Widmark A
Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
[TBL] [Abstract][Full Text] [Related]
11. Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain.
Borras JM; Font R; Solà J; Macia M; Tuset V; Arenas M; Eraso A; Verges R; Farré N; Pedro A; Mollà M; Algara M; Solé JM; Mira M; Espinàs JA
Radiother Oncol; 2020 Oct; 151():200-205. PubMed ID: 32771615
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
